Hemogenyx Pharmaceuticals
Carina has research experience in nanoparticle drug delivery systems for the treatment of various cancers and in regenerative tissue engineering for the treatment of osteoarthritis.
She conducted research at Hunter College for three years, studying the mechanical and chemical properties of exosomes in order to develop targeted drug delivery and elucidate cancer metastasis pathways. At Hunter, she also worked on creating novel iron-oxide nanoparticles to be used for effective imaging, as well as for drug delivery. Carina was an Amgen Scholar at Columbia University, where she developed and optimized an injectable, engineered cartilage matrix to facilitate the healing of osteoarthritic wounds utilizing synovial stem cells.
She received a B.A. degree in Chemistry, summa cum laude, from Macaulay Honors College at Hunter College.
This person is not in any offices
Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals plc is a pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases.